Trials / Conditions / Chronic Kidney Disease stage3

Chronic Kidney Disease stage3

23 registered clinical trials studyying Chronic Kidney Disease stage3 — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatmen NCT06394544	Universidade Federal Fluminense	N/A
Completed	Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease. NCT06863467	Revelation Biosciences, Inc	Phase 1 / Phase 2
Not Yet Recruiting	Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease NCT04827290	Centre Hospitalier Saint Joseph Saint Luc de Lyon	N/A
Completed	Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinic NCT06094920	University Medical Center Groningen	Phase 4
Recruiting	Evaluation of the Effectiveness of Platelet-based and Microvesicle-based Assays to Predict Thrombotic and Blee NCT06026436	Assistance Publique Hopitaux De Marseille	N/A
Recruiting	Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD NCT07309094	Cardenal Herrera University	—
Unknown	Validation and Evaluation of a Newly Developed Mobile Diet App NCT04336033	Universiti Putra Malaysia	N/A
Terminated	A Pragmatic Approach to CKD Patient Education NCT05138419	University of Arkansas	N/A
Terminated	Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathy NCT05543928	OPKO Health, Inc.	Phase 3
Completed	Study of Sulphoraphane in Chronic Kidney Disease NCT05153174	University of Rochester	Phase 1
Completed	Effect of Intradialytic Exercises in Chronic Kidney Disease Patients NCT06293092	Cairo University	N/A
Completed	PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System NCT06037265	PAVmed Inc.	N/A
Completed	Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management NCT05630729	3-C Institute for Social Development	N/A
Completed	Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients NCT05264584	Ain Shams University	N/A
Unknown	Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous NCT04311645	Assiut University	Phase 2
Unknown	Renal Denervation in Chronic Kidney Disease - RDN-CKD Study NCT04264403	University of Erlangen-Nürnberg Medical School	N/A
Withdrawn	Pathophysiological Characterization of the Neuromuscular Function of a Population With Multiple Comorbidities NCT03998917	Centre Hospitalier le Mans	—
Completed	Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients NCT04617431	National Taiwan University Hospital	N/A
Unknown	Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidn NCT04961931	Medical University of Lodz	N/A
Unknown	Flywheel Exercise for CKD NCT03582982	Washington D.C. Veterans Affairs Medical Center	N/A
Completed	EMPRA (EMPagliflozin and RAs in Kidney Disease) NCT03078101	Medical University of Vienna	Phase 2
Completed	A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir NCT03144635	Kyushu University	Phase 4
Unknown	The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Dis NCT01410617	Imam Khomeini Hospital	Phase 2 / Phase 3